|
AEVIS VICTORIA SA / Key word(s): 9 Month figures Ad hoc announcement pursuant to Art. 53 LR Fribourg, 3 November 2023 AEVIS VICTORIA SA (AEVS:SW) – Continued organic growth in the third quarter of 2023 AEVIS VICTORIA SA (AEVIS) announces that it achieved revenues of CHF 710.2 million as at 30 September 2023, down due to the change in consolidation scope and the absence of M&A activity. On a comparable basis, total revenues would have reached CHF 702.9 million (2022: CHF 676.1m), representing an organic growth of 4.0%. At the same time, the hospitality and healthcare operating divisions again achieved organic growth. The Group’s hospitality division MRH Switzerland AG (ex-Victoria Jungfrau AG) achieved revenues of CHF 134.9 million in the first nine months, up by 10.8%, of which 7.3% organic growth driven in particular by the destinations of Zermatt and Interlaken. Swiss Medical Network SA realized consolidated revenues of CHF 566.3 million in the first nine months, representing an organic growth of 3.1%. Due to the change in consolidation scope and the deconsolidation of Réseau de l’Arc SA (ex-Hôpital du Jura Bernois SA) since 31 December 2022, reported revenue was 13.3% lower than in the previous year. The third quarter is traditionally weaker due to the summer break. Réseau de l'Arc SA itself posted revenues of CHF 109.8 million (2022: CHF 95.2m), up 15.2%, including an organic growth of 4.2%. Réseau de l'Arc SA will publish its annual results separately, in accordance with the directives of the canton of Berne. For further information: AEVIS VICTORIA SA - Investing for a better life End of Inside Information |
1764151 03-Nov-2023 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.
Special
